New EGFR-targeting combos may improve response rates and durability for patients with head and neck cancer.
Dr. Ranee Mehra
Advertisement
Director of Head and Neck Oncology in the Division of Hematology/Oncology and associate director for Clinical Research at the University of Maryland School of Medicine.
Articles by Dr. Ranee Mehra
Dr. Ranee Mehra shares guidance on recurrence, quality-of-life concerns and clinical trials for patients with head and neck cancers and caregivers.
Advertisement
Latest Updated Articles
Advertisement
Advertisement